Thus, the bone-metastatic potential of prostate cancer cell lines correlates with the expression of the receptor tyrosine kinase α-PDGFR and, thereby, with a stronger AKT activation [125,126]. This evidence concerns the gene NTRK1 and prostate carcinoma.